Détails du rapport Vaer
Âge: 44 ans
Région : Outside US
- Patient décédé?
- Renseignements sur les vaccins
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
- Date de réception du rapport
- Date à laquelle le formulaire est complèté
- Date de vaccination
- Date d’apparition
- Nombre de jours (date d’apparition – date de vaccination)
- Description de l’événement indésirable
intermenstrual bleeding; off-label use; interchange of vaccine products; bleeding; had 3 periods within 26 days heavy bleeding with each; this is a spontaneous report received from contactable reporter (consumer or other non hcp) from the regulatory authority-web. regulatory number: gb-mhra-webcovid-202202152027412770-apgja (ra). other case identifier: gb-mhra-adr 26608350 (ra). a 44-year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 20jan2022 (lot number: fu5254), at the age of 44 years as dose 2 (initial pfizer dose), single for covid-19 immunization. relevant medical history included: "immunodeficiency" (unknown if ongoing), notes: taking other treatments or medicines, not listed above, known to lower the immune response; "hidradenitis" (unknown if ongoing) and "suspected covid-19" (ongoing), notes: unsure when symptoms started. the patient last menstrual period (lmp) date on 14feb2022. the patient's concomitant medications were not reported. past drug history included: humira for hidradenitis. vaccination history included: covid-19 vaccine astrazeneca (dose 1, single), administration date: 17feb2021 for covid-19 immunization. patient was not breast feeding at the time of report. patient had not tested positive for covid-19 since having the vaccine. patient was not enrolled in a clinical trial. the following information was reported: off label use (medically significant) with onset 20jan2022, outcome "unknown", described as "off-label use"; interchange of vaccine products (medically significant) with onset 20jan2022, outcome "unknown", described as "interchange of vaccine products"; intermenstrual bleeding (medically significant) with onset 24jan2022, outcome "not recovered", described as "intermenstrual bleeding"; haemorrhage (medically significant) with onset 2022, outcome "not recovered", described as "bleeding" and heavy menstrual bleeding (non-serious) with onset 2022, outcome "unknown", described as "had 3 periods within 26 days heavy bleeding with each". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04oct2021) positive, notes: yes - positive covid-19 test. this report doesn't relate to possible inflammation of the heart (myocarditis or pericarditis). no follow-up attempts are possible. no further information is expected
- Données de laboratoire
test date: 20211004; test name: covid-19 virus test; test result: positive ; comments: yes - positive covid-19 test
- Liste des symptômes
heavy menstrual bleeding haemorrhage interchange of vaccine products sars-cov-2 test off label use intermenstrual bleeding
- Patient décédé?
- Date de décès
- Anomalie congénitale
- Vaccin administré par :
- Vaccin acheté par :
- Visite d’un patient à l’urgence?
- Patient hospitalisé?
- Séjour à l’hôpital
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Maladie actuelle
suspected covid-19 (unsure when symptoms started)